DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr | ₹-1,218 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-974 Cr |
Mar2023 | ₹-629 Cr |
Mar2022 | ₹-1,276 Cr |
Mar2021 | ₹-1,040 Cr |
Mar2020 | ₹-1,218 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-974 Cr | Negative | |
Mar2023 | ₹-629 Cr | Negative | |
Mar2022 | ₹-1,276 Cr | Negative | |
Mar2021 | ₹-1,040 Cr | Negative | |
Mar2020 | ₹-1,218 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,701.3 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹121,197.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics | |
MANKIND PHARMA | ₹94,475.7 Cr | -2.5% | -8.3% | 5.2% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -2.6% |
8.3% |
7.9% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses